RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Antitumor Immunity: Role of NK Cells and Extracellular Vesicles in Cancer Immunotherapy.
Antitumor Immunity: Role of NK Cells and Extracellular Vesicles in Cancer Immunotherapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
免疫系统在识别和清除发生改变的肿瘤细胞中起着至关重要的作用。然而,肿瘤会发展出逃避机体天然免疫防御的机制。因此,基于机体免疫细胞,已开发出特异性识别/靶向肿瘤细胞的方法,例如通过免疫细胞的激活、定向极化和训练。这一策略被称为细胞免疫治疗。治疗肿瘤疾病的一种有前景的策略是基于NK细胞的免疫治疗。NK细胞能够在无需预先激活的情况下识别并摧毁转化细胞以及MHC-I表达降低的肿瘤细胞。免疫治疗中的一种新方法是使用来源于NK细胞的细胞外囊泡(EVs)。NK细胞来源EVs的主要优势在于其体积小以及向肿瘤组织内更好的渗透性。本综述的目的是系统呈现关于抗肿瘤免疫机制以及NK细胞和细胞外囊泡在癌症免疫治疗中作用的现有信息。目前正在进行的利用NK细胞和细胞外囊泡进行抗癌治疗的临床和临床前研究将为癌症领域的研究人员提供有价值的见解。
The immune system plays a crucial role in recognizing and eliminating altered tumor cells.
However, tumors develop mechanisms to evade the body's natural immune defenses.
Therefore, methods for specifically recognizing/targeting tumor cells, for instance, through the activation, directed polarization, and training of immune cells, have been developed based on the body's immune cells. This strategy has been termed cellular immunotherapy. One promising strategy for treating tumor diseases is NK cell-based immunotherapy. NK cells have the ability to recognize and destroy transformed cells without prior activation as well as tumor cells with reduced MHC-I expression.
A novel approach in immunotherapy is the use of extracellular vesicles (EVs) derived from NK cells. The main advantages of NK cell-derived EVs are their small size and better tissue penetration into a tumor.
The aim of this review is to systematically present existing information on the mechanisms of antitumor immunity and the role of NK cells and extracellular vesicles in cancer immunotherapy. Clinical and preclinical studies utilizing NK cells and extracellular vesicles for anticancer therapy currently underway will provide valuable insights for researchers in the field of cancer.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。